TickerGuard
Buy Day today: Neutral (46) Mixed market breadth · no major macro event
SNTI

Senti Biosciences Inc

Healthcare · Biotechnology

0.1651$ -23.9% vs. previous close Closing price · As of: Oct 30, 2026

Filings

Filings

Listed US companies must report material events to the Securities and Exchange Commission. This page lists the filings of Senti Biosciences Inc (SNTI) with date, type and a link to the original document.

Filings SNTI
Date Type Filing Original
10/27/2026 Current report (8-K) Senti Biosciences Holdings, Inc. (SNTI): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers; Other Events View report ↗
10/26/2026 Current report (8-K) Senti Biosciences Holdings, Inc. (SNTI): Entry into a Material Definitive Agreement; Termination of a Material Definitive Agreement; Completion of Acquisition or Disposition of Assets; Unregistered Sales of Equity Securities; Financial Statements and Exhibits View report ↗
10/15/2026 Current report (8-K) Senti Biosciences Holdings, Inc. (SNTI): Submission of Matters to a Vote of Security Holders View report ↗
10/13/2026 Current report (8-K) Senti Biosciences Holdings, Inc. (SNTI): Other Events View report ↗
09/24/2026 Current report (8-K) Senti Biosciences Holdings, Inc. (SNTI): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers View report ↗
09/04/2026 Current report (8-K) Senti Biosciences Holdings, Inc. (SNTI): Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant; Financial Statements and Exhibits View report ↗
09/02/2026 Current report (8-K) Senti Biosciences Holdings, Inc. (SNTI): Entry into a Material Definitive Agreement; Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing View report ↗
08/20/2026 Current report (8-K) Senti Biosciences Holdings, Inc. (SNTI): Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant View report ↗
07/15/2026 Current report (8-K) Senti Biosciences Holdings, Inc. (SNTI): Entry into a Material Definitive Agreement; Results of Operations and Financial Condition; Changes in Control of Registrant; Regulation FD Disclosure; Other Events; Financial Statements and Exhibits View report ↗

Showing the 100 most recent filings of the selected type.

Data as of: October 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Filings: SEC EDGAR

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?